Surgery Partners, Inc.
SGRY Healthcare Medical Care Facilities
Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.
- Revenue
- +2.75%
- EPS
- −500.0%
- Free cash flow
- −60.6%
- Total debt
- +4.92%
Quarter to June 2026, against a year earlier
Follow SGRY
Alert me
Surgery Partners, Inc. (SGRY) EBITDA
Surgery Partners, Inc.'s EBITDA for fiscal 2025 was $588.4M, up 13.0% from $520.9M in fiscal 2024. Over the twelve months to 30 June 2026 it was $583.3M. Over the past ten years it has ranged from $154.1M (fiscal 2018) to $588.4M (fiscal 2025) — the current reading is the highest in ten years. Surgery Partners, Inc. ranks 10th of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $588.4M | 12.96% |
| FY2024 | $520.9M | 13.17% |
| FY2023 | $460.3M | (2.58%) |
| FY2022 | $472.5M | 14.60% |
| FY2021 | $412.3M | 42.86% |
| FY2020 | $288.6M | (10.54%) |
| FY2019 | $322.6M | 109.34% |
| FY2018 | $154.1M | (28.85%) |
| FY2017 | $216.6M | (10.05%) |
| FY2016 | $240.8M | 27.47% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $147.8M | 36.35% |
| Mar 2026 | $108.4M | (38.65%) |
| Dec 2025 | $176.7M | 17.49% |
| Sep 2025 | $150.4M | (4.51%) |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| SGRY Surgery Partners, Inc. | $583.3M |
| ACHC Acadia Healthcare Company, Inc. compare | $539.9M |
| BKD Brookdale Senior Living Inc. compare | $436.2M |
| AVAH Aveanna Healthcare Holdings Inc. compare | $307.9M |
| MD Pediatrix Medical Group, Inc. compare | $236.8M |
| NHC National HealthCare Corporation compare | $190.4M |
| ADUS Addus HomeCare Corporation compare | $172.9M |
| ASTH Astrana Health, Inc. compare | $168.1M |
| GRDN Guardian Pharmacy Services, Inc. compare | $117.6M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on SGRY
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement